Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide with implications for heart and kidney disorders.
Petros Andrikopoulos,Judith Aron-Wisnewsky,Antonis Myridakis,Trine Nielsen,Solia Adriouch,Bridget Holmes,Julien Chilloux,Sara Vieira-Silva,Gwen Falony,Fabrizio Andreelli,Eugeni Belda,Julius Kieswich,Kanta Chechi,Francesc Puig-Castellvi,Mickael Chevalier,Emmanuelle Le Chatelier,Lesley Hoyles,Renato Alves,Gerard Helft,Richard Isnard,Lars Køber,Luis Pedro Coelho,Christine Rouault,Dominique Gauguier,Jens Peter Gøtze,Edi Prifti,Jean-Daniel Zucker,Fredrik Bäckhed,Henrik Vestergaard,Torben Hansen,Jean-Michel Oppert,Matthias Blüher,Jens Nielsen,Jeroen Raes,Peer Bork,Michael Stumvoll,Oluf Pedersen,S. Dusko Ehrlich,Karine Clément,Marc-Emmanuel Dumas,Rima M. Chakaroun,Sofia Kirke Forslund,Joe-Elie SALEM,Michael T Olanipekun,Muhammad M Yaqoob
DOI: https://doi.org/10.1101/2022.11.08.22282073
2022-11-10
MedRxiv
Abstract:Objectives: The host-microbiota co-metabolite trimethylamine N-oxide (TMAO) is linked to increased thrombotic and cardiovascular risks. Here we, sought to i) characterize which host variables contribute to fasting serum TMAO levels in real-life settings ii) identify potential actionable therapeutic means related to circulating TMAO. Design: We applied "explainable" machine learning, univariate-, multivariate- and mediation analyses of fasting plasma TMAO concentration and a multitude of bioclinical phenotypes in 1,741 adult Europeans of the MetaCardis study. We expanded and validated our epidemiological findings in mechanistic studies in human renal fibroblasts and a murine model of kidney fibrosis following TMAO exposure. Results: Next to age, kidney function was the primary variable predicting circulating TMAO in MetaCardis, with microbiota composition and diet playing minor, albeit significant roles. Mediation analysis revealed a causal relationship between TMAO and kidney function decline that strengthened at more severe stages of cardiometabolic disease. We corroborated our findings in preclinical models where TMAO exposure augmented conversion of human renal fibroblasts into myofibroblasts and increased kidney scarring in vivo. Mechanistically, TMAO aggravated kidney fibrosis due to ERK1/2 hyperactivation synergistically with TGF-{beta}1 signaling. Consistent with our findings, patients receiving next-generation glucose-lowering drugs with reno-protective properties, had significantly lower circulating TMAO when compared to propensity-score matched control individuals. Conclusion: After age, kidney function is the major determinant of fasting circulating TMAO in adults. Our findings of lower TMAO levels in individuals medicated with reno-protective anti-diabetic drugs suggests a clinically actionable intervention for decreasing TMAO-associated excess cardiovascular risk that merits urgent investigation in human trials.